Nissay Asset Management Corp Japan ADV Has $1.02 Million Stock Position in DENTSPLY SIRONA Inc (NASDAQ:XRAY)

Nissay Asset Management Corp Japan ADV increased its position in shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 6.2% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 23,167 shares of the medical instruments supplier’s stock after purchasing an additional 1,350 shares during the quarter. Nissay Asset Management Corp Japan ADV’s holdings in DENTSPLY SIRONA were worth $1,021,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. BlackRock Inc. grew its position in shares of DENTSPLY SIRONA by 1.3% during the 1st quarter. BlackRock Inc. now owns 15,819,802 shares of the medical instruments supplier’s stock worth $614,283,000 after buying an additional 202,335 shares during the period. State Street Corp increased its holdings in DENTSPLY SIRONA by 0.7% during the first quarter. State Street Corp now owns 9,783,406 shares of the medical instruments supplier’s stock worth $380,856,000 after buying an additional 69,053 shares during the last quarter. Janus Henderson Group PLC increased its holdings in DENTSPLY SIRONA by 26.9% during the first quarter. Janus Henderson Group PLC now owns 7,456,461 shares of the medical instruments supplier’s stock worth $289,534,000 after buying an additional 1,578,869 shares during the last quarter. Atlanta Capital Management Co. L L C increased its holdings in DENTSPLY SIRONA by 6.3% during the first quarter. Atlanta Capital Management Co. L L C now owns 7,210,190 shares of the medical instruments supplier’s stock worth $279,972,000 after buying an additional 425,854 shares during the last quarter. Finally, First Eagle Investment Management LLC increased its holdings in DENTSPLY SIRONA by 11.9% during the first quarter. First Eagle Investment Management LLC now owns 6,992,516 shares of the medical instruments supplier’s stock worth $271,519,000 after buying an additional 744,134 shares during the last quarter. Institutional investors and hedge funds own 95.52% of the company’s stock.

A number of equities analysts recently weighed in on XRAY shares. HC Wainwright boosted their target price on shares of DENTSPLY SIRONA from $38.00 to $50.00 and gave the stock a “neutral” rating in a report on Monday, June 15th. Credit Suisse Group restated a “buy” rating and set a $50.00 target price on shares of DENTSPLY SIRONA in a report on Sunday, April 19th. Bank of America upped their price objective on shares of DENTSPLY SIRONA from $54.00 to $56.00 and gave the company a “buy” rating in a report on Monday, July 20th. BidaskClub downgraded shares of DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a report on Thursday, July 9th. Finally, Barclays decreased their price objective on shares of DENTSPLY SIRONA from $42.00 to $40.00 and set an “equal weight” rating on the stock in a report on Monday, May 11th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and seven have assigned a buy rating to the stock. DENTSPLY SIRONA currently has a consensus rating of “Hold” and a consensus target price of $49.40.

XRAY opened at $44.60 on Friday. DENTSPLY SIRONA Inc has a twelve month low of $31.58 and a twelve month high of $60.87. The company has a 50-day simple moving average of $43.62 and a 200 day simple moving average of $45.81. The company has a quick ratio of 1.36, a current ratio of 2.02 and a debt-to-equity ratio of 0.33. The stock has a market capitalization of $9.91 billion, a price-to-earnings ratio of 120.54, a P/E/G ratio of 4.06 and a beta of 1.05.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Friday, May 8th. The medical instruments supplier reported $0.43 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.41 by $0.02. DENTSPLY SIRONA had a net margin of 2.12% and a return on equity of 10.70%. The business had revenue of $873.30 million during the quarter, compared to analysts’ expectations of $873.00 million. During the same quarter in the prior year, the business posted $0.49 earnings per share. DENTSPLY SIRONA’s revenue was down 7.7% compared to the same quarter last year. Sell-side analysts anticipate that DENTSPLY SIRONA Inc will post 1.4 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 9th. Investors of record on Friday, September 25th will be given a dividend of $0.10 per share. The ex-dividend date is Thursday, September 24th. This represents a $0.40 annualized dividend and a yield of 0.90%. DENTSPLY SIRONA’s dividend payout ratio is 16.33%.

In related news, insider William E. Newell sold 10,000 shares of the company’s stock in a transaction dated Thursday, June 4th. The shares were sold at an average price of $48.23, for a total transaction of $482,300.00. Following the completion of the sale, the insider now owns 17,219 shares of the company’s stock, valued at $830,472.37. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Michael C. Alfano sold 2,500 shares of the stock in a transaction dated Friday, May 29th. The stock was sold at an average price of $46.27, for a total transaction of $115,675.00. Following the completion of the transaction, the director now directly owns 15,669 shares of the company’s stock, valued at approximately $725,004.63. The disclosure for this sale can be found here. Corporate insiders own 0.53% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

Featured Article: What is a balanced fund?

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc (NASDAQ:XRAY).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.